What is the initial management of seizure-like activity in a long-term care setting?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Management of Seizure-Like Activity in Long-Term Care

For active, non-self-limiting seizures in long-term care residents, immediately administer IV lorazepam 4 mg slowly (2 mg/min) after ensuring airway patency and stabilizing vital signs. 1, 2, 3

Immediate Stabilization (First 5 Minutes)

  • Ensure airway, breathing, and circulation are secured first before any medication administration 2
  • Position the patient to prevent aspiration and maintain airway patency 3
  • Monitor oxygen saturation continuously, as hypoxia exacerbates both seizures and any underlying cerebral pathology 2
  • Establish IV access if not already present 1, 3
  • Check fingerstick glucose immediately to rule out hypoglycemia as a reversible cause 1, 4

First-Line Pharmacologic Treatment

Administer IV lorazepam 4 mg at a rate not exceeding 2 mg/min for patients 18 years and older with ongoing seizure activity 3

  • If seizures cease after the initial dose, no additional lorazepam is required 3
  • If seizures continue or recur after a 10-15 minute observation period, administer an additional 4 mg IV dose slowly 3
  • Critical warning: The most important risk with lorazepam is respiratory depression—ventilatory support equipment must be immediately available 3
  • Monitor for excessive sedation, particularly in elderly long-term care residents who may have prolonged effects 3

Second-Line Agent Selection (If Seizures Persist After Benzodiazepines)

If seizures continue despite optimal benzodiazepine dosing, immediately administer one of three equally effective second-line agents: fosphenytoin, levetiracetam, or valproate. 1

Agent-Specific Dosing:

  • Fosphenytoin: 15-20 mg PE/kg IV at maximum rate of 150 mg PE/min, with continuous cardiac monitoring 1, 5
  • Levetiracetam: 60 mg/kg IV (up to 4500 mg) over 15 minutes 1
  • Valproate: 40 mg/kg IV (up to 3000 mg) over 10 minutes 1

Selection Considerations:

  • All three agents have similar efficacy for terminating seizures (approximately 45-47% success rate) 1
  • Levetiracetam has the lowest risk of hypotension (0.7% vs 3.2% for fosphenytoin vs 1.6% for valproate) 1
  • Fosphenytoin requires cardiac monitoring due to arrhythmia risk and must not exceed 50 mg/min in adults 5
  • Intubation rates are similar across all three agents (16.8-26.4%) 1

Critical Decision Point: Long-Term Anticonvulsant Therapy

Do NOT initiate long-term anticonvulsant therapy for a single, self-limiting seizure occurring within 24 hours of an acute medical event (such as stroke, infection, or metabolic derangement). 1, 2

  • A single seizure in the context of acute illness does not constitute epilepsy and prophylactic treatment may impair neurological recovery 1, 2
  • Only initiate maintenance anticonvulsants if: recurrent seizures occur beyond the acute period, or if seizures continue despite treatment of the underlying cause 1, 4

Diagnostic Workup During Active Management

While managing the seizure, simultaneously investigate reversible causes:

  • Obtain stat basic metabolic panel to identify electrolyte abnormalities (hyponatremia, hypocalcemia, hypomagnesemia) 4
  • Check renal and hepatic function, as organ failure commonly provokes seizures in long-term care residents 4
  • Review medication list for proconvulsant drugs or recent medication changes/withdrawals 4
  • Measure temperature every 4 hours—fever >37.5°C requires investigation as infection is a common seizure precipitant in this population 2
  • Consider non-contrast head CT if new focal neurological deficits are present or if the patient has fall risk/anticoagulation 2
  • Obtain EEG monitoring if the patient has unexplained reduced consciousness after apparent seizure termination to rule out non-convulsive status epilepticus 1, 2

Common Pitfalls in Long-Term Care Settings

  • Avoid intramuscular phenytoin—absorption is erratic and peak levels may not occur for 24 hours, making it inappropriate for acute seizure management 5
  • Do not delay treatment waiting for IV access; buccal or intranasal benzodiazepines can be used if IV access is not immediately available 6
  • Propylene glycol toxicity can occur with high-dose diazepam (>900 mg/day), particularly in residents with renal dysfunction or alcoholism—monitor for metabolic acidosis 7
  • Elderly patients are at higher risk for prolonged sedation and respiratory depression with benzodiazepines—have reversal agents and airway equipment ready 3

Post-Seizure Monitoring and Care

  • Continue vital sign monitoring every 15-30 minutes for at least 2 hours after seizure termination, watching specifically for recurrent seizure activity 1, 2
  • Assess swallowing function before allowing any oral intake, as aspiration risk is significantly elevated in the post-ictal period 2
  • Document seizure characteristics (duration, focal vs generalized, post-ictal state) to guide further workup 1
  • Avoid aggressive blood pressure lowering if cerebrovascular ischemia is suspected, as this may worsen perfusion 2

When to Transfer to Acute Care

Transfer to the emergency department is indicated if:

  • Seizures do not terminate after appropriate first- and second-line therapy 1
  • Respiratory depression requiring mechanical ventilation occurs 3
  • Underlying cause cannot be identified or corrected in the long-term care setting 4
  • Recurrent seizures develop despite treatment 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Seizures in Watershed Stroke

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Medical causes of seizures.

Lancet (London, England), 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.